COMP <GO>
RDWR vs NUTX // EV/EBITDA & P/E VALUATION
Radware Ltd. (NASDAQ) VS. Nutex Health Inc. (NASDAQ) • 15-METRIC TALLY: RDWR 3
— NUTX 8
▲ EV/EBITDA & P/E VALUATION LEADER: NUTX
LAST: $36.64 (-1.40%) • MKT CAP: $1.55B
valuation
77.4x
LAST: $210.10 (-1.19%) • MKT CAP: $1.44B
valuation
4.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RDWR VS. NUTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | RDWR | NUTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 80.70% | 50.80% | +29.90 | RDWR | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.70% | 85.00% | -81.30 | NUTX | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 77.4x | 4.6x | +72.80 | NUTX | /valuation <GO> |
| Free Cash Flow Yield | 2.68% | 17.07% | -14.39 | NUTX | /fcf-yield <GO> |
| Operating Margin | 3.80% | 31.50% | -27.70 | NUTX | /operating-margins <GO> |
| Net Profit Margin | 6.70% | 8.10% | -1.40 | NUTX | /net-margins <GO> |
| Revenue Growth (YoY) | 9.80% | 82.40% | -72.60 | NUTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 3.75 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | NUTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.3 | 46.7 | +15.57 | RDWR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 71.1x | 17.1x | +54.00 | NUTX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.55B | $1.44B | $111.4M | RDWR | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | RDWR REV | NUTX REV | RDWR GROSS % | NUTX GROSS % | RDWR FCF | NUTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $301.9M | $875.3M | 80.7% | 50.8% | $41.6M | $245.6M |
| FY 2024 | $274.9M | $479.9M | 80.6% | 40.9% | $66.3M | $20.8M |
| FY 2023 | $261.3M | $247.6M | — | — | -$3.5M | $1.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RDWR // BETA —
NUTX // BETA —